For Vax Providers, Flu Season Off to a Running Start
It’s flu season again, and more than 690,000 people in the U.S. have already been vaccinated, reports healthcare analytics service SDI.
swine flu
As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
Bioguard Wound Dressings Beat Swine Flu In Independent Study
Derma Sciences, a developer of wound care products, announced that its Bioguard Barrier Dressings effectively safeguarded against the H1N1 “swine flu” virus in an independent laboratory study.
Biotech News Out of Quebec
Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.
First Swine Flu Vaccines Approved
The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports.
BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows
BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test.
Independent Study Validates BioNeutral’s Ygiene
In an independent study, BioNeutral’s Ygiene antimicrobial formulation eliminated a particularly dangerous type of mold in record time.
Frontrunners Emerge In Swine Flu Vaccine Race
Just days after the World Health Organization declared a swine flu pandemic, Fierce Biotech reports that two pharmaceutical companies are already racing to complete clinical trials of their H1N1 vaccines.
Companies Rush to Create Swine Flu Vaccines
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.